Molecular mechanisms in neurologic disorders
Related Experiment Video
Updated: Oct 4, 2026

Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
1Department of Pediatrics, Obstetrics and Gynecology, University of Arizona College of Medicine and the Steele Memorial Children's Research Center, Tucson 85724-5073, USA.
Abstract:
Although many pediatric neurologic disorders, such as epilepsy and mental retardation, are the result of a combination of genetic and environmental factors, many others are the result of mutations of single genes. Most of these single gene traits are inherited in autosomal dominant, autosomal recessive, or X-linked fashion. The diversity of mutations that are responsible for these diseases produces variability in phenotypic expression. However, there are other important features of many neurologic disorders that cannot be explained by standard models of mendelian inheritance. This review focuses on recently described mechanisms, such as genomic imprinting, germline mosaicism, mitochondrial inheritance, and triplet repeat expansion. The diagnostic evaluation, prognostic significance, and recurrence risk for specific neurogenetic disorders is correlated with these underlying disease mechanisms.
Related Concept Videos
Disorders of the Nervous Tissue
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Excitatory and Inhibitory Effects of Neurotransmitters
Parkinson Disease ll: Pathophysiology
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Neurochemical Transmission: Sites of Drug Action
Parkinson's Disease: Overview